The chemical-biological interface: developments in automated and miniaturised screening technology.
The rapidly changing developments in genomics and combinatorial chemistry, generating new drug targets and large numbers of compounds, have caused a revolution in high-throughput screening technologies. Key to this revolution has been the introduction of robotics and automation, together with new biological assay technologies (e.g., homogeneous time resolved fluorescence). With ever increasing workloads, together with economic and logistical constraints, miniaturisation is rapidly becoming essential for the future of high-throughput screening and combinatorial chemistry. This is evident from the introduction of high-density microtitre plates, small volume liquid handling robots and associated detection technology.
Houston
J G
JG
Lead Discovery Unit, Glaxo Wellcome Medicines Research Centre, Stevenage, Hertfordshire, UK. jgh2794@ggr.co.uk
Banks
M
M
D001331:Automation; D002626:Chemistry, Pharmaceutical; D008904:Miniaturization; D012371:Robotics